Viewing StudyNCT00215722



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00215722
Status: UNKNOWN
Last Update Posted: 2007-04-06
First Post: 2005-09-20

Brief Title: XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer
Sponsor: Grupo de Investigacao do Cancro Digestivo
Organization: Grupo de Investigacao do Cancro Digestivo

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-07
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2008-07
Completion Date Type: ESTIMATED
First Submit Date: 2005-09-20
First Submit QC Date: September 20 2005
Study First Post Date: 2005-09-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2007-04-05
Last Update Post Date: 2007-04-06
Last Update Post Date Type: ESTIMATED